Acrylate Patch Tests in 87 Nail Artists and Cosmetologists
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of a fictional work or activity setting. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
This review asks a narrow question about workplace or activity-related skin evidence while preserving the paper’s actual population, denominator, design and timepoint.
What did researchers study?
| Study element | Reported detail |
|---|---|
| Population | 87 nail artists/cosmetologists who suspected nail cosmetics, within 72,244 female patch-tested patients |
| Design | Retrospective contact-allergy surveillance-network analysis |
| Timepoint | 2004 through 2013 |
| Key result | 47.1% of the 87 reacted to at least one (meth)acrylate; 27 reacted to HEMA and 26 each to HPMA and hydroxyethyl acrylate. |
What the numbers do—and do not—show
47.1% of the 87 reacted to at least one (meth)acrylate; 27 reacted to HEMA and 26 each to HPMA and hydroxyethyl acrylate.
Important limitation: The 87 were selected symptomatic referrals, coupled reactions complicate attribution, and the percentage is not risk among all nail professionals.
Questionnaires, examinations, patch tests, surveillance records and environmental measurements answer different questions. A positive test shows sensitization under test conditions; it does not automatically prove that a workplace material caused current symptoms. A symptom report is not the same as a clinician-confirmed diagnosis, and a referred series cannot estimate risk in the whole occupation.
How to use this evidence in real life
- Write down the exact task, product, material, glove, cleaner, plant, food or equipment involved.
- Record timing: when symptoms begin, where they appear, and what changes away from work.
- Bring labels or safety information to occupational health or a clinician rather than testing workplace chemicals on your own skin.
- Keep required protective procedures in place while alternatives are reviewed.
- Seek prompt care for rapidly spreading redness, drainage, fever, severe pain, breathing symptoms or major loss of function.
Primary and authoritative sources
- Primary research record: PubMed PMID 25589046
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis overview
- American Academy of Dermatology: eczema skin care
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
Keep the population, denominator, study design and limitations attached to the result. Use the evidence to ask better clinical and exposure-control questions—not to promise a universal outcome.